Maravai LifeSciences Holdings Inc (MRVI)

38.09 +1.00  +2.70% NASDAQ Oct 18, 16:00 38.09 0.00  0.00% After-Hours: 18:32 USD

Maravai LifeSciences Holdings Cash from Financing (TTM):

-18.82M for June 30, 2021
View 4,000+ financial data types
Browse...
View Full Chart

Cash from Financing (TTM) Chart

Export Data
Save Image
Print Image

Historical Cash from Financing (TTM) Data

View and export this data going back to 2020. Start your Free Trial
Export Data Date Range:
Data for this Date Range  
June 30, 2021 -18.82M
March 31, 2021 14.67M
   
Dec. 31, 2020 53.21M

There is no data for the selected date range.

An error occurred. Please try again by refreshing your browser or contact us with details of your problem.

Advertisement

Cash From Financing Definition

Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.

Read full definition.

Cash from Financing (TTM) Benchmarks

Codex DNA Inc 122.03M
BioCryst Pharmaceuticals Inc 201.71M
Agios Pharmaceuticals Inc -492.17M

Cash from Financing (TTM) Range, Past 5 Years

Minimum -18.82M Jun 2021
Maximum 53.21M Dec 2020
Average 16.36M

News

Top Biotech Stocks for Q4 2021
Yahoo 09/20 14:57 ET
Advertisement

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}

Please note that this feature is only available as an add-on to YCharts subscriptions.


Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{root.upsell.info.call_to_action}} No credit card required.

Already a subscriber? Sign in.